Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leu... von SHAH, Neil P, KANTARJIAN, Hagop M, KHOROSHKO, Nina, PAQUETTE, Ronald L, DEININGER, Michael, COLLINS, Robert H, OTERO, Irma, HUGHES, Timothy, BLEICKARDT, Eric, STRAUSS, Lewis, FRANCIS, Stephen, HOCHHAUS, Andreas, KIM, Dong-Wook, REA, Delphine, DORLHIAC-LLACER, Pedro E, MILONE, Jorge H, VELA-OJEDA, Jorge, SILVER, Richard T, KHOURY, H. Jean, CHARBONNIER, Aude

Volltext

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial von Kantarjian, Hagop, Pasquini, Ricardo, Hamerschlak, Nelson, Rousselot, Philippe, Holowiecki, Jerzy, Jootar, Saengsuree, Robak, Tadeusz, Khoroshko, Nina, Masszi, Tamas, Skotnicki, Aleksander, Hellmann, Andrzej, Zaritsky, Andrey, Golenkov, Anatoly, Radich, Jerald, Hughes, Timothy, Countouriotis, Athena, Shah, Neil

Volltext

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month m... von Kantarjian, Hagop, Cortes, Jorge, Kim, Dong-Wook, Dorlhiac-Llacer, Pedro, Pasquini, Ricardo, DiPersio, John, Müller, Martin C., Radich, Jerald P., Khoury, H. Jean, Khoroshko, Nina, Bradley-Garelik, M. Brigid, Zhu, Chao, Tallman, Martin S.

Volltext

Pregnancy Management and Outcomes In Women With Myeloproliferative Disease von Polushkina, Eugenia S., Shmakov, Roman G., Vinogradova, Maria A., Sokolova, Manana A., Khoroshko, Nina D.

Volltext

The Role of Imatinib Plasma Level in the Achievment of Complete Cytogenetic Response (CCyR) in Chronic Myeloid Leukemia (CML) Therapy von Kutsev, Sergey, Oxenjuk, Oxana, Mordanov, Sergey, Shatokhin, Yuri, Pospelova, Tatiana, Khoroshko, Nina, Turkina, Anna

Volltext

Phase II, randomized, multicenter, comparative study of peginterferon-α-2a (40 kD) (Pegasys®) versus interferon α-2a (Roferon®-A) in patients with treatment-naïve, chronic-phase ch... von Lipton, Jeffrey H., Khoroshko, Nina, Golenkov, Anatoly, Abdulkadyrov, Kudrat, Nair, Krishnan, Raghunadharao, Digumarti, Brummendorf, Tim, Yoo, Kisook, Bergstrom, Bengt

Volltext

Clinical Significance of Additional Chromosomal Abnormalities In Ph-Positive and Ph-Negative Cells In Patients with Chronic Myeloid Leukemia Treated by Tyrosine Kinase Inhibitors von Turkina, Anna G., Vinogradova, Olga, Vorontsova, Alexandra, Chelysheva, Ekaterina, Lazareva, Olga, Gusarova, Galina, Aseeva, Elena, Khoroshko, Nina

Volltext

Results of Tyrosine Kinase Inhibitors (TKI) Therapy of Patients (Pts) with Chronic Myeloid Leukemia (CML) In Clinical Practice Analysed In the Frame of International Research Proje... von Turkina, Anna G., Kulikov, Sergey, Abdulkadirov, Kudrat, Kutsev, Sergey, Golenkov, Anatoly, Ivanova, Valentina, Pospelova, Tatiana, Konstantinova, Tatiana, Lazareva, Olga, Khoroshko, Nina

Volltext

Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-ph... von Lipton, Jeffrey H, Khoroshko, Nina, Golenkov, Anatoly, Abdulkadyrov, Kudrat, Nair, Krishnan, Raghunadharao, Digumarti, Brummendorf, Tim, Yoo, Kisook, Bergstrom, Bengt

Volltext

Dasatinib 140 Mg Once Daily (QD) Demonstrates Equivalent Efficacy and Improved Safety Compared with 70 Mg Twice Daily (BID) in Patients with Accelerated Phase Chronic Myeloid Leuke... von Kantarjian, Hagop M., Kim, Dong-Wook, Dorlhiac-Llacer, Pedro, Pasquini, Ricardo, Khoroshko, Nina, DiPersio, John F., Müller, Martin C, Bradley-Garelik, M. Brigid, Zhu, Chao, Tallman, Martin S.

Volltext

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib : a randomized phase 2 trial. Commentary von SCHIFFER, Charles A, KANTARJIAN, Hagop, SKOTNICKI, Aleksander, HELLMANN, Andrzej, ZARITSKY, Andrey, GOLENKOV, Anatoly, RADICH, Jerald, HUGHES, Timothy, COUNTOURIOTIS, Athena, SHAH, Neil, PASQUINI, Ricardo, HAMERSCHLAK, Nelson, ROUSSELOT, Philippe, HOLOWIECKI, Jerzy, JOOTAR, Saengsuree, ROBAK, Tadeusz, KHOROSHKO, Nina, MASSZI, Tamas

Volltext

Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASM (PRIMARY MYELOFIBROSIS) – AS ONE OF THE REASONS OF THE BUDD-CHIARI SYNDROME. CLINICAL CASE OF A YOUNG PATIENT von Manana Alexandrovna Sokolova, Nina Tsvetaeva, Galina Sukhanova, Sergei Vasiliev, Andrey Misurin, Maria Dmitrievna Sanatko, Maria Nareiko, Valeria Rudakova, Elena Semenova, Nina Dmitrievna Khoroshko

Volltext

Prognostic Value of P-Glycoprotein and Leukocyte Differentiation Antigens in Chronic Myeloid Leukemia von Stavrovskaya, Alla, Turkina, Anna, Sedyakhina, Natalia, Stromskaya, Tatjana, Zabottna, Tatjana, Khoroshko, Nina, Baryshnikov, Anatoly

Volltext

Fluorescence In Situ Hybridization Studies of Interphase Nuclei for Assessing Response to Therapy in Patients with Chronic Myeloid Leukemia von Kobzev, Yuri, Domracheva, Elena, Zakharova, Adel’, Khoroshko, Nina, Turkina, Anna, Dewald, Gordon

Volltext

Effects of cytapheresis on cell cycle distribution of peripheral blood and bone marrow cells in some hematological malignancies von Kotelnikov, Valery M., Kasatkina, Valentina V., Dultsina, Solomea M., Sarytcheva, Tereza G., Kalinin, Nicolaj N., Kovaleva, Lidia G., Poljanskaja, Aelita M., Isajev, Valentin G., Khoroshko, Nina D., Lishmanova, Nadja G., Gusejnov, Tejmur N., Melikjan, Anait L., Petrov, Michail M., Goldberg, Viktor E., Kozinets, Gennadi I.

Volltext